SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-200117
Filing Date
2023-08-01
Accepted
2023-08-01 10:53:55
Documents
3
Group Members
15186111 CANADA INC.20231089 PARENT, INC.ANSBERT GADICKE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d525703dsc13da.htm SC 13D/A 80804
2 EX-99.18 d525703dex9918.htm EX-99.18 6165
3 GRAPHIC g525703g0731201112173.jpg GRAPHIC 7307
  Complete submission text file 0001193125-23-200117.txt   98987
Mailing Address 399 BOYLSTON STREET, SUITE 1100 BOSTON MA 02116
Business Address 399 BOYLSTON STREET, SUITE 1100 BOSTON MA 02116 6174259200
BioImpact Capital LLC (Filed by) CIK: 0001687078 (see all company filings)

IRS No.: 364818254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 30 DUNCAN STREET, LOWER NORTH SUITE TORONTO A6 M5V 2C3
Business Address 30 DUNCAN STREET, LOWER NORTH SUITE TORONTO A6 M5V 2C3 833-833-1967
Reunion Neuroscience Inc. (Subject) CIK: 0001865482 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-94088 | Film No.: 231130150
SIC: 8000 Services-Health Services